Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 52, Issue 9 (Sep 2014)

Issues

Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care

Josephine M. Keyzer
  • Corresponding author
  • Center of Research on Psychology in Somatic Diseases (CoRPS), Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Johannes J. Hoffmann
  • Medical and Scientific Affairs Hematology, Abbott Diagnostics Europe, Wiesbaden-Delkenheim, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Lianne Ringoir
  • Center of Research on Psychology in Somatic Diseases (CoRPS), Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Karin C. Nabbe / Jos W. Widdershoven
  • Center of Research on Psychology in Somatic Diseases (CoRPS), Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
  • Department of Cardiology, TweeSteden Ziekenhuis, Tilburg, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Victor J. Pop
  • Center of Research on Psychology in Somatic Diseases (CoRPS), Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-04-29 | DOI: https://doi.org/10.1515/cclm-2013-0791

Abstract

Background: Chronic heart failure is a common disease with a high morbidity and mortality. In primary care, brain natriuretic peptide (BNP) is used for excluding heart failure. The Dutch and European Society of Cardiology heart failure guidelines apply two BNP cut-off levels without making distinction for gender and age. The aim of our study was to establish BNP reference ranges for use in primary care.

Methods: We investigated BNP values of 9447 eligible subjects in a primary care laboratory. For establishing the reference ranges in various age and gender classes we used the Bhattacharya method.

Results: Analysis of variance demonstrated that BNP data were significantly dependent on age and gender (p<0.001 and p=0.002, respectively), with the age effect being the strongest. Further, we found that the reference ranges were significantly higher than the cut-off values used in the heart failure guidelines, particularly in elderly subjects. For example, the proportion of individuals with a BNP value higher than the 29 pmol/L cut-off increased from approximately 5% in the youngest group to no less than about 50% in the oldest subjects.

Conclusions: BNP reference ranges need to be age- and gender-specific. When applying a single cut-off, many healthy subjects, especially the elderly, would be falsely diagnosed as having elevated BNP, and referred for further unnecessary diagnostics.

Keywords: Bhattacharya statistics; brain natriuretic peptide (BNP); chronic heart failure; primary care; reference ranges

References

  • 1.

    Poole-Wilson PA. Chronic heart failure: cause, pathophysiology, prognosis, clinical manifestations, investigations. In: Julian DG, Gamm AJ, Fox FK, Hall RJ, Poole-Wilson PA, editors. Diseases of the heart. London: Bailliere-Tindall, 1989:24–36.Google Scholar

  • 2.

    Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137–46.CrossrefPubMedGoogle Scholar

  • 3.

    Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004;25:1614–9.PubMedCrossrefGoogle Scholar

  • 4.

    Engelfriet PM, Hoogenveen RT, Poos MJ, Blokstra A, van Baal PH, Verschuren WM. Heart failure: epidemiology, risk factors and future. RIVM rapport 260401006. Bilthoven: RIVM, 2012. Available from: http://www.rivm.nl/bibliotheek/rapporten/260401006.html. Accessed August 30, 2013.

  • 5.

    Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315–22.PubMedCrossrefGoogle Scholar

  • 6.

    Stewart S, Ekman I, Ekman T, Oden A, Rosengren A. Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes 2010;3:573–80.Google Scholar

  • 7.

    Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009;119: 515–23.Web of ScienceGoogle Scholar

  • 8.

    Mosterd A, Reitsma JB, Grobbee DE. ACE inhibition and hospitalisation rates for heart failure, the Netherlands 1980–1999. The end of an epidemic? Heart 2002;87:388–92.Google Scholar

  • 9.

    Slobbe LC, Smit JM, Groen J, Poos MJ, Kommer GJ. Cost of illness in the Netherlands 2007: trends in healthcare expenditure 1999–2010. RIVM rapport 270751023. Bilthoven: RIVM, 2011. Available from: http://www.rivm.nl/bibliotheek/rapporten/270751023.html. Accessed August 30, 2013.

  • 10.

    De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89–94.CrossrefPubMedGoogle Scholar

  • 11.

    Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 1994;235:561–76.Google Scholar

  • 12.

    Davidson NC, Struthers AD. Brain natriuretic peptide. J Hypertens 1994;12:329–36.PubMedGoogle Scholar

  • 13.

    Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161–7.Google Scholar

  • 14.

    Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994;343:440–4.Google Scholar

  • 15.

    Struthers AD. Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? Br Med J 1994;308:1615–9.Google Scholar

  • 16.

    Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349–53.Google Scholar

  • 17.

    Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998;95:519–29.PubMedGoogle Scholar

  • 18.

    Sagnella GA. Measurement and importance of plasma brain natriuretic peptide and related peptides. Ann Clin Biochem 2001;38:83–93.PubMedCrossrefGoogle Scholar

  • 19.

    McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J 2012;33:1787–847.Google Scholar

  • 20.

    Hoes AW, Voors AA, Rutten FH, Van Lieshout J, Janssen PG, Walma EP. NHG-standaard Hartfalen. 2e herziening. Huisarts Wet 2010;53:368–89.Google Scholar

  • 21.

    Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745–51.CrossrefGoogle Scholar

  • 22.

    DeFilippi C, van Kimmenade RR, Pinto YM. Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 2008;101:82–8.PubMedCrossrefGoogle Scholar

  • 23.

    McCullough PA, Kuncheria J, Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med 2003;4:3–12.Google Scholar

  • 24.

    McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev 2003;8:335–8.Google Scholar

  • 25.

    Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 2005;46: 610–20.PubMedCrossrefGoogle Scholar

  • 26.

    Siebenhofer A, Ng LL, Plank J, Berghold A, Hodl R, Pieber TR. Plasma N-terminal pro-brain natriuretic peptide in type 1 diabetic patients with and without diabetic nephropathy. Diabet Med 2003;20:535–9.Google Scholar

  • 27.

    Tanabe A, Naruse M, Wasada T, Naruse K, Yoshimoto T, Omori Y, et al. Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. Eur J Endocrinol 1995;132:693–8.Google Scholar

  • 28.

    Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976–82.CrossrefPubMedGoogle Scholar

  • 29.

    Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002;90:254–8.CrossrefPubMedGoogle Scholar

  • 30.

    Ringoir L, Pedersen SS, Widdershoven JW, Pouwer F, Keyzer JM, Romeijnders A, et al. Beta-blockers and depression in elderly hypertension patients in primary care. Family Medicine (in press).Google Scholar

  • 31.

    Mongia SK, La’ulu SL, Apple FS, Ler R, Murakami MM, Roberts WL. Performance characteristics of the Architect brain natriuretic peptide (BNP) assay: a two site study. Clin Chim Acta 2008;391:102–5.Web of ScienceGoogle Scholar

  • 32.

    Bhattacharya CG. A simple method of resolution of a distribution into Gaussian components. Biometrics 1967;23:115–35.CrossrefPubMedGoogle Scholar

  • 33.

    Baadenhuijsen H, Smit JC. Indirect estimation of clinical chemical reference intervals from total hospital patient data: application of a modified Bhattacharya procedure. J Clin Chem Lab Med 1985;23:829–39.Google Scholar

  • 34.

    Knudsen CW, Riis JS, Finsen AV, Eikvar L, Müller C, Westheim A, et al. Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoe: effect of age and gender. Eur J Heart Fail 2004;6:55–62.CrossrefPubMedGoogle Scholar

About the article

Corresponding author: Josephine M. Keyzer, Department of Medical and Clinical Psychology, CoRPS, Tilburg University, PO Box 90153, 5000 LE Tilburg, The Netherlands, Phone: +31 618049590, E-mail:


Received: 2013-09-20

Accepted: 2014-03-31

Published Online: 2014-04-29

Published in Print: 2014-09-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2013-0791.

Export Citation

©2014 by De Gruyter. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Michele Emdin, Alberto Aimo, Claudio Passino, and Giuseppe Vergaro
European Journal of Heart Failure, 2017, Volume 19, Number 4, Page 549
[2]
Goran P. Koracevic
The American Journal of Emergency Medicine, 2016, Volume 34, Number 4, Page 750
[3]
Wen-Tao He, Masayuki Mori, Xue-Feng Yu, and Tsugiyasu Kanda
Lipids in Health and Disease, 2016, Volume 15, Number 1
[4]
Jeanette Normann
Zeitschrift für Gerontologie und Geriatrie, 2015, Volume 48, Number 2, Page 187
[5]
Yohei Tateishi, Akira Tsujino, Jumpei Hamabe, Akira Tsuneto, Koji Maemura, Osamu Tasaki, Nobutaka Horie, Tsuyoshi Izumo, Kentaro Hayashi, and Izumi Nagata
Journal of the Neurological Sciences, 2014, Volume 345, Number 1-2, Page 83

Comments (0)

Please log in or register to comment.
Log in